首页> 外国专利> METHOD OF CONTROL OF EFFICIENCY OF ANTITUMOR TREATMENT OF WOMEN WITH MALIGNANT GENITALIA TUMORS

METHOD OF CONTROL OF EFFICIENCY OF ANTITUMOR TREATMENT OF WOMEN WITH MALIGNANT GENITALIA TUMORS

机译：控制恶性生殖器肿瘤的女性前期治疗效率的方法

页面导航

摘要
著录项
相似文献

摘要

FIELD: medicine, oncology. SUBSTANCE: invention relates to methods of control of patients state in the process of treatment and in periods of dispensary inspection. Method involves study of hematological, biochemical and immunological indices of peripheral blood in carrying out the specific antitumor treatment of patients with malignant tumors of genitalia and use of different kinds of curative effects. Assay of efficiency of curative measures is carried out by digital indices of hemoglobin level, 112 ± 5.0; absolute count of lymphocytes, 0.8 ± 0.06; large granulocyte-containing lymphocytes, 12.4 ± 0.3; index of monocytic-macrophagal transformation of monocytes, 38.2 ± 2.0; ratio of superoxide dismutase to total peroxidase activity of lymphocytes, 16.0 ± 4.9; ratio of superoxide dismutase to total peroxidase activity of neutrophiles, 9.4 ± 2.3; ratio of vitamins E and A content in neutrophiles, 1.2 ± 0.2; ratio of vitamin E content in erythrocytes and plasma, 2.0 ± 0.3. Analysis of results of study of the above indicated indices in 227 patients with malignant tumors shows that given digital values of these indices are objective proof of efficiency of carrying out curative measures and favorable prognosis of patients state. Different digital values indicate the absence of effect, unfavorable prognosis and necessity of carrying out additional curative treatments. Method ensures to obtain objective estimation of treatment to be carried out and to realize prognosis of patients viability. EFFECT: improved method of control of antitumor treatment. 3 ex

机译：领域：医学，肿瘤学。发明领域本发明涉及在治疗过程中和在药房检查期间控制患者状态的方法。该方法涉及研究外周血的血液学，生化学和免疫学指标，以对生殖器恶性肿瘤患者进行特异性抗肿瘤治疗，并利用各种疗效。通过血红蛋白水平的数字指标112和plusmn进行治疗措施效率的测定。 5.0;淋巴细胞的绝对计数为0.8及以上; 0.06;含粒细胞的大淋巴细胞，12.4及以上; 0.3;单核细胞的巨噬细胞单核-巨噬细胞转化指数，38.2＆plusmn; 2.0;淋巴细胞超氧化物歧化酶与总过氧化物酶活性之比为16.0 4.9;中性粒细胞超氧化物歧化酶与总过氧化物酶活性之比9.4 2.3;中性粒细胞中维生素E和A的含量之比为1.2以上0.2;红细胞与血浆中维生素E含量之比为2.0以上; 0.3。对227例恶性肿瘤患者上述指标的研究结果分析表明，这些指标的给定数字值客观地证明了实施治愈措施的效率和患者状态的良好预后。不同的数字值表示无效，预后不良以及必须进行其他治愈性治疗的必要性。该方法确保获得要进行的治疗的客观估计并实现患者生存能力的预后。效果：改进的抗肿瘤治疗控制方法。 3前

著录项

公开/公告号RU2170433C2

专利类型
公开/公告日2001-07-10

原文格式PDF
申请/专利权人 ROSTOVSKIJ NAUCHNO-ISSLEDOVATELSKIJ ONKOLOGICHESKIJ INSTITUT;SIDORENKO JURIJ SERGEEVICH;ROZENKO LJUDMILA JAKOVLEVNA;FRANTSIJANTS ELENA MIKHAJLOVNA;SPIVAK INNA GENNADEVNA;
展开▼

申请/专利号RU19990115278
发明设计人 ROZENKO L.JA.;SIDORENKO JU.S.;FRANTSIJANTS E.M.;SPIVAK I.G.;
展开▼

申请日1999-07-08
分类号G01N33/48;
国家 RU
入库时间 2022-08-22 01:10:48

相似文献

专利
外文文献
中文文献